Eshwar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.57 Cr
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 2.85 Cr
- Revenue Growth -34.98%
- Profit Growth -248.28%
- Ebitda -6328.54%
- Net Worth -197.39%
- Total Assets -13.44%
About Eshwar Pharmaceuticals
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232TG2008PTC059164
- Company No.
059164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2008
- Date of AGM
28 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc-Hyderabad
Industry
What products or services does Eshwar Pharmaceuticals Private Limited offer?
Eshwar Pharmaceuticals Private Limited offers a wide range of products and services, including Antifungal Injection, Tablet & Syrup, Fluconazole Tablet.
Who are the key members and board of directors at Eshwar Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Eshwar Pharmaceuticals.
Eshwar Pharmaceuticals Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 34.98% decrease. The company also saw a substantial fall in profitability, with a 248.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 197.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eshwar Pharmaceuticals?
In 2018, Eshwar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹2.85 Cr
Charges Breakdown by Lending Institutions
- Andhra Bank : 2.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Aug 2014 | Andhra Bank | ₹2.85 Cr | Satisfied |
How Many Employees Work at Eshwar Pharmaceuticals?
Unlock and access historical data on people associated with Eshwar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eshwar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eshwar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
